By Taylor Abarca in · October 14, 2015 · No comments
Taylor Abarca (Bakemeyer) is the Social Media Web Specialist at the University of Colorado Cancer Center. Contact her at Taylor.Bakemeyer [at] ucdenver.edu.
No comments yet.
June 12, 2017 · No comments
CU Cancer Center study pinpoints promising link in the chain of hedgehog signaling that, when broken, could reduce the metastatic potential of breast cancer.
Brigatinib first drug to offer over 1-year control of ALK-positive lung cancer post-crizotinib
May 17, 2017 · Comments Off on Brigatinib first drug to offer over 1-year control of ALK-positive lung cancer post-crizotinib